top of page
  • Team Marketing

Revolutionizing Laparoscopic Cholecystectomy: HydroLap Study Published in iScience Journal

We are excited to share some groundbreaking news with you! The remarkable study on the novel surgical tool, HydroLap, developed by Dr. Dinesh Vyas and his team, has been published in the prestigious iScience journal. This study marks a significant milestone in the field of laparoscopic cholecystectomies, offering new hope for patients suffering from gangrenous gallbladders and more.

Acute cholecystitis, characterized by inflammation of the gallbladder, poses a significant challenge in surgical procedures. It is estimated that approximately 15% of laparoscopic surgeries are performed to treat gangrenous gallbladders, incurring substantially higher costs compared to other laparoscopic procedures. These cases are not only medically demanding but also have the potential to result in medical malpractice litigations.

In response to this pressing issue, Dr. Dinesh Vyas and his dedicated team have embarked on a decade-long journey to develop an innovative solution. The HydroLap, a groundbreaking tool, utilizes hydrodissection technology during laparoscopic cholecystectomies. This revolutionary approach enables surgeons to delicately remove the dead tissue while preserving the healthy tissue surrounding the gallbladder, thereby enhancing patient outcomes.

The publication of this study in the esteemed iScience journal highlights the significance and impact of the HydroLap tool in the medical community. It underscores the dedication and expertise of Dr. Vyas and his team in striving for excellence and pushing the boundaries of surgical innovation.

We are thrilled to share this extraordinary accomplishment, which paves the way for a more efficient and effective treatment for gangrenous gallbladders and other medical conditions.

With FDA approval expected in 2023, the HydroLap tool holds immense promise for transforming the landscape of laparoscopic cholecystectomies and improving the lives of countless patients.

Stay tuned for further updates on this groundbreaking innovation, as we continue to explore new frontiers in surgical technology and patient care.


bottom of page